HLS Therapeutics (HLS) AGM 2024 summary

Opening remarks and agenda

• Meeting opened with a welcome and instructions for virtual participation, including Q&A and voting procedures.

• Forward-looking statements and associated risks were highlighted, referencing recent filings for detailed risk factors.

• Officers and director nominees were introduced, and the agenda was outlined: financial statements, election of directors, and auditor reappointment.

Board and executive committee updates

• Eight nominees for director positions were present and introduced, with their election to be decided during the meeting.

Overview of voting outcomes

• All matters put to a ballot, including the election of eight directors and the reappointment of the auditor, passed with requisite shareholder support.

• Voting results will be filed on SEDAR+ and a press release will disclose the election of each director.